TransCelerate accreditation

TransCelerate Accreditation

ICH GCP training (Good Clinical Practice E6 (R2)) performed by BioResearch, which is dedicated for our employees and external entities, was accredited by TransCelerate Biopharma Inc. and so we joined „GCP Mutual Recognition Program"

TransCelerate organisation aim is to unify GCP trainings for Research Teams and confirms that registered trainings fulfill basic program requirements.

GCP certificates which are issued after finishing the training are accepted by Sponsors and representatives of pharmaceuticals companies all over teh world.

BioResearch training was placed on the list of trainings of Transcelerate Biopharma Inc, which is presented at following link: http://www.transceleratebiopharmainc.com/gcp-training-attestation/training-providers/

What makes the training in BioResearch unique and valuable?

Practical approach supported by many years of experience of the Speakers, who as researchers carried out dozens of projects.

Aim

Preparation of researchers and research centers to perform delegated duties in accordance with GCP, local and international law.

To whom

To experienced and beginning researchers, research team: coordinators, pharmacists, lab technicians, nurses and other involved in the project.

Go back

News

Dr Jarosław Długołęcki

We are pleased to welcome a new member of the BRG medical expert team. Mr Jarosław Długołęcki, (M.D.) - doctor with extensive knowledge and 16-years’ experience in clinical studies at the international level.

Read more …

Badania kliniczne faz wczesnych szczepionek – wyzwania w obliczu nowych zagrożeń

Szczepienia ochronne niezaprzeczalnie należą do jednych z najbardziej przełomowych odkryć nowoczesnej medycyny.

Read more …

Publication in the Biotechnology magazine

We invite you to read our publication in the Biotechnology magazine - the largest industry portal in Poland, the latest information from the sectors: biotechnology, cosmetology, pharmacy and technologies.

Read more …

Promising antidiabetic drug

We have started an interesting study with a promising antidiabetic drug. The drug is designed in the form of prolonged-action tablets, which action leads to increased insulin secretion.

 

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2020 © Bio Research Group. All rights reserved.

 

scroll to top ▲